CRS Says ‘Miller Amendment’ Won’t Ban CBD, Other

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
190
CRS Says ‘Miller Amendment’ Won’t Ban CBD, Other Cannabinoids from Hemp

An analysis conducted by the Congressional Research Service has determined that not all hemp cannabinoids will be prohibited under a recently proposed amendment for the upcoming Farm Bill. The legislative agency stated that the amendment, which would crack down on the distribution of unregulated hemp products, wouldn’t affect nonpsychoactive natural compounds from the hemp crop, including CBD.

The amendment to the farm bill, dubbed the Miller Amendment, was introduced by Representative Mary Miller of Illinois. It was approved by the House Committee on Agriculture in May 2024.

The amendment defines hemp in a different way, differentiating between industrial hemp, which includes crops grown for fibers and food in the form of grain, as well as plants grown for flowers. Psychoactive hemp substances are derived from these flowers.

As approved by the House committee, the new draft of the farm bill redefines the 0.3% limit for hemp, combining THCA and delta-9 THC and permits only naturally derived or naturally occurring nonintoxicating compounds.

This is different from language in the 2018 Farm Bill, which legalized the production of industrial hemp. This bill defines hemp as any cannabis plant that does not contain more than 0.3% delta-9 THC. The 2018 bill’s definition of hemp also includes any part of the plant, including the seeds and all derivatives, cannabinoids, extracts, salts of isomers, salts, acids and isomers.

The exclusion of synthetic compounds in the recent amendment is consistent with a ruling made by the U.S. Drug Enforcement Agency (DEA) earlier this year regarding HHC, an intoxicating synthetic compound. In its ruling, the DEA determined that the aforementioned compound didn’t naturally occur in the cannabis plant and could only be obtained synthetically. This, the federal agency noted, meant it could not be included in the definition of hemp.

Some states in the country are considering implementing or have implemented similar bans for synthetic hemp compounds such as delta-10 THC, delta-8 THC, THCP, THC-O-acetate and others.

The Congressional Research Service noted that while the amendment didn’t define intoxicating, it would ban hemp products with quantifiable amounts of cannabinoids such as THC, which have similar effects on people or animals. The legislative agency added that products that contained marijuana and marijuana-derived compounds included THC, CBD and other cannabinoids, remained under the jurisdiction of the U.S. Food and Drug Administration (FDA).

Other changes to the farm bill include the elimination or reduction of background checks and testing requirements for license applicants. Steps would also be taken to eliminate the currently imposed 10-year ban that makes it impossible for individuals previously convicted of crimes associated with a controlled substance to acquire a license.

Companies such as Astrotech Corp. (NASDAQ: ASTC) are likely to follow how this piece of legislation progresses on Capitol Hill since it could impact the future trajectory of the hemp industry.

NOTE TO INVESTORS: The latest news and updates relating to Astrotech Corp. (NASDAQ: ASTC) are available in the company’s newsroom at https://cnw.fm/ASTC

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer


Astrotech Corp. (ASTC) Stock Research Links

ASTC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Enanta Pharmaceuticals Highlights Fiscal Q1 2025 Performance

Updated Category News Views 188

Enanta Pharmaceuticals Reports Financial Highlights for Q1 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology firm, has revealed its financial results for the first fiscal quarter ending December 31, 2024. This quarter is seen as a crucial period for the company as it expands its innovative drug portfolio targeting viral and immunological...

Continue Reading
Friedman Industries Reports Impressive First Quarter Growth

Updated Category News Views 98

Friedman Industries Reports Significant First Quarter Growth Friedman Industries, Incorporated (NASDAQ/GS: FRD) has announced remarkable results for the first quarter of the fiscal year, showcasing a strong performance that has positioned the company favorably in the steel manufacturing sector. The results released highlight not only the growth in earnings but also an...

Continue Reading
From Doubt to Delicious: The Rise of Raising Cane's

Updated Category News Views 308

Overcoming Doubt: The Birth of Raising Cane's The journey of Raising Cane's is not just about chicken fingers; it's a story of perseverance. Founded by Todd Graves, the chain has become a testament to how challenges can fuel passion and success. Graves faced significant skepticism from those who thought the concept was flawed due to its limited menu. Motivation Behind...

Continue Reading
Understanding Japan's Impact on US Tech Stock Dynamics

Updated Category News Views 371

The Influence of Japan's Real Rates on US Markets The current landscape of the S&P 500 bull market has been subject to various influences, and surprisingly, one of the most significant factors is not a domestic recession in the US but rather Japan's extraordinarily negative real interest rates compared to those in the US. This insightful perspective comes from BCA...

Continue Reading
Ocean Ledger Secures Funding to Enhance Coastal Risk Solutions

Updated Category News Views 171

Ocean Ledger Secures Funding for Coastal Risk Management Ocean Ledger, a promising geospatial analytics startup, has recently completed a successful funding round, securing $900K to enhance its capabilities in coastal risk management. This investment is poised to support the development of innovative solutions aimed at forecasting coastal risks, benefitting various...

Continue Reading